O’Melveny Advises Zeda on US$52 Million Series B Funding3月 07, 2023
FOR IMMEDIATE RELEASE
SILICON VALLEY—March 7, 2023—O’Melveny advised Zeda, Inc., a global leader in advanced 3D manufacturing and nanotech solutions for the medical, space, aerospace, and defense industries, on its US$52 million Series B funding round.
The transaction was announced on March 7.
The funding round was jointly led by Boutique Venture Partners, Berkeley Catalyst Fund, DOV Management, and Solvay Ventures. New investors Michelin, Taiyo Nippon Sanso Corporation, and Fives Group also participated in the Series B round.
With this funding, Zeda has raised a total of US$68 million and will use the proceeds to address the global growth in demand for metal 3D printing.
Zeda is a leading technology solutions company focused on bettering lives by investing in cutting-edge technologies, innovative companies, and groundbreaking ideas. The company’s foundation combines expertise from diverse industries, including AM, nanotech, precision manufacturing, and incubating new ideas.
The O’Melveny team advising Zeda was led by Silicon Valley M&A partners Warren Lazarow and Brian Covotta, and included counsel AJ Talt and associate Thasos Athens.
It’s more than what you do: it’s how you do it. Across sectors and borders, in board rooms and courtrooms, we measure our success by yours. And in our interactions, we commit to making your O’Melveny experience as satisfying as the outcomes we help you achieve. Our greatest accomplishment is ensuring that you never have to choose between premier lawyering and exceptional service. So, tell us. What do you want to achieve? Visit us at www.omm.com; read our Insights 2023 report; hear what our lawyers, business professionals, and clients have to say in the “Our DNA” video series, learn more in our firm at-a-glance; and find us on LinkedIn, Twitter, Facebook, Instagram, and YouTube.
O’Melveny & Myers LLP
+1 213 430 8024
# # #
Zeda issued the following announcement:
Zeda, Inc. (Formerly PrinterPrezz / Vertex Manufacturing) Closes $52 Million Series B Financing Round
Funding will accelerate the company’s geographic footprint and medical product expansion in the US and Asia.
March 07, 2023 12:00 ET | Source: Zeda, Inc.
FREMONT, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Zeda, Inc. (previously PrinterPrezz / Vertex Manufacturing), a global leader in advanced 3D manufacturing and nanotech solutions for the medical, space, aerospace, and defense industries, closed a $52 million equity and debt financing for a total capital raise of $68 million to date.
The Series B round included participation by multiple new institutional and strategic investors, including Michelin, Taiyo Nippon Sanso Corporation (a Mitsubishi Chemical Group company), and Fives Group. It was jointly led by existing investors: Boutique Venture Partners, Berkeley Catalyst Fund, DOV Management, and Solvay Ventures.
The company will primarily use the proceeds to fund its new advanced manufacturing digital foundry in Cincinnati, Ohio, as well as expand our facilities globally to address the growth in demand for metal 3D printing in the medical, aerospace, defense, space, and energy applications as well as expansion into the Asian market for its medical implant applications. This follows the announcement last year of an agreement with the Singapore Healthcare Clusters and the National Additive Manufacturing Innovation Cluster (NAMIC) to grow the 3D-printed implant market in the region.
Shri Shetty, CEO of Zeda (formerly PrinterPrezz / Vertex Manufacturing), said, “Zeda is seeing exponential growth in our served markets, driven by our regulated-industry partners and products, due to the global environment and localizing of supply chains. We are delighted to have closed a substantial round, particularly with the current economic headwinds. This further validates our vision for the company and the capabilities of our exceptional team to execute against our business plan.”
Dr. Rami El Assal, Managing General Partner and Co-founder of Boutique Venture Partners, which specializes in early-stage investments in life sciences and healthcare, commented, “We’re delighted to continue to support Zeda in their Series B round. What impresses me most about the company is its ability to provide a complete solution for medical devices from concept to production – dramatically speeding innovation.”
DOV Management Founder & CEO David You stated, “As this funding round shows, there is a market even in tough times for industry leaders like Zeda. Few challenges are as complex as revitalizing localized manufacturing and securing critical supply chains. We’re pleased to invest in Zeda as we believe, leveraging advanced manufacturing and technology, it’s best positioned to deliver reliable, high-quality products across multiple regulated industries and applications.”
Mr. Kobayashi, Head of the Corporate Office of Innovation at Taiyo Nippon Sanso Corporation (a Mitsubishi Chemical Group company), commented, “We are very excited to be a partner of Zeda and are impressed with Zeda’s quality control system for printed implants. We also believe that TNSC’s technologies, including purity control of printing atmosphere and surface modification of printed parts, will further enhance Zeda’s process.”
About Zeda, Inc.
Zeda (formerly PrinterPrezz / Vertex Manufacturing) is a leading technology solutions company. Our objective is to better lives by investing in cutting-edge technologies, innovative companies, and groundbreaking ideas. Our foundation combines expertise from diverse industries, including AM, nanotech, precision manufacturing, and incubating new ideas. Servicing highly regulated industries such as medical, space, defense, and aerospace, Zeda’s mission is to build it all better together.
Frank De Maria